Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04942977
Other study ID # TSB2014
Secondary ID 484/14/EC
Status Completed
Phase N/A
First received
Last updated
Start date May 28, 2019
Est. completion date December 7, 2020

Study information

Verified date June 2021
Source Catcronic Salut SL
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cardiac rehabilitation after an acute coronary syndrome is recognised in the latest guidelines and recommendations published by the major scientific societies as a class I indication. Despite this evidence, the number of patients entering such programmes in Europe is still around 30%. The present study aims to validate a new comprehensive Telerehabilitation System to provide support for cardiac rehabilitation, to optimize it and to test its usefulness in terms of improving adherence to physical exercise and cardiovascular risk parameters.


Description:

To validate this approach, a clinical trial was designed to compare a 10-month program of cardiac telerehabilitation with a conventional 8-week centre-based cardiac rehabilitation. Seventy patients will be randomized 1:1 to cardiac telemonitoring or centre-based cardiac rehabilitation. The characteristics of the interventions do not allow the study to be blinded to the patient or the professional. However, the analyses, stress tests and questionaires will be carried out in a masked form without the assigned group being identified by the researchers carrying out the examinations. Assessment for primary and main secondary outcomes will be performed at baseline and at ten months of follow-up, and will include self-reported physical activity (IPAQ), VO2max, blood test, general emotional distress, Adherence to the Mediterranean Diet, quality of life, vital signs, returning to work. The hypothesis is that patients randomised to prolonged telemonitoring will demonstrate higher levels of physical activity at 10-month follow-up, compared to patients in the centre-based cardiac rehabilitation programme, as well other positive changes in the cardiovascular risk profile.


Recruitment information / eligibility

Status Completed
Enrollment 67
Est. completion date December 7, 2020
Est. primary completion date December 7, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 72 Years
Eligibility Inclusion Criteria: - Signed informed consent - Patients after uncomplicated acute coronary syndrome of both sexes. - Patients completing a maximal or symptom-limited CPET without angina or electrical ischaemia. - Age equal to or less than 72 years. Exclusion Criteria: - Refusal of informed consent - Advanced biological age. - Kidney failure (GFR < 30ml/min/1.73 m2). - Liver failure (GOT >2 times normal value). - Ejection fraction less than 50%. - Uncontrolled blood pressure (>140/90 mmHg). - Uncontrolled heart failure. - Dissecting aortic aneurysm. - Uncontrolled ventricular tachycardia or other dangerous ventricular arrhythmias. - Aortic or mitral valve disease. - Recent systemic or pulmonary embolism. - Active or recent thrombophlebitis. - Acute infectious diseases. - Uncontrolled supraventricular arrhythmias or tachycardia. - Repeated or frequent ventricular ectopic activity. - Moderate pulmonary hypertension. - Ventricular aneurysm. - Uncontrolled diabetes, thyrotoxicosis, myxedema, - Conduction disorders such as: complete atrioventricular block. Left bundle branch block. - Wolf-Parkinson-White syndrome. - Fixed rate pacing. - Severe anaemia. - Psychoneurotic disorders. - Neuromuscular, musculoskeletal and arthritic disorders that may limit activity. may limit activity.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
telemonitoring
The system consists of the following elements: Professional website at the hospital, which allows: To set up an individualised care plan To establish the patient's risk profile and targets for improvement. Long-term monitoring of the evolution of cardiovascular risk factors and events that occurred Advise the patient on self-management strategies. Mobile application software with the following functions: Scheduled exercise sessions Medication reminder Measurement reminder (weight, blood pressure, heart rate, waist circumference, etc.) Messages: Inbox folder for system messages and messages generated by professionals for a specific patient or video conference. Training monitor: guides the patient in the performance of their exercise. Access to certified health information for patients
Other:
Centre-based cardiac rehabilitation
The physical activity consisted of a workout routine and aerobic cycling training. Patients are instructed to perform 150 minutes per week of moderate physical activity when the hospital phase finishes.

Locations

Country Name City State
Spain Ernesto Dalli Peydró Valencia
Spain Hospital Politécnico Universitario La Fe Valencia

Sponsors (1)

Lead Sponsor Collaborator
Catcronic Salut SL

Country where clinical trial is conducted

Spain, 

References & Publications (6)

Ambrosetti M, Abreu A, Corrà U, Davos CH, Hansen D, Frederix I, Iliou MC, Pedretti RF, Schmid JP, Vigorito C, Voller H, Wilhelm M, Piepoli MF, Bjarnason-Wehrens B, Berger T, Cohen-Solal A, Cornelissen V, Dendale P, Doehner W, Gaita D, Gevaert AB, Kemps H, Kraenkel N, Laukkanen J, Mendes M, Niebauer J, Simonenko M, Zwisler AO. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2020 Apr 7. pii: 2047487320913379. doi: 10.1177/2047487320913379. [Epub ahead of print] — View Citation

Frederix I, Hansen D, Coninx K, Vandervoort P, Vandijck D, Hens N, Van Craenenbroeck E, Van Driessche N, Dendale P. Medium-Term Effectiveness of a Comprehensive Internet-Based and Patient-Specific Telerehabilitation Program With Text Messaging Support for Cardiac Patients: Randomized Controlled Trial. J Med Internet Res. 2015 Jul 23;17(7):e185. doi: 10.2196/jmir.4799. — View Citation

Frederix I, Vanhees L, Dendale P, Goetschalckx K. A review of telerehabilitation for cardiac patients. J Telemed Telecare. 2015 Jan;21(1):45-53. doi: 10.1177/1357633X14562732. Epub 2014 Dec 4. Review. — View Citation

Reibis R, Salzwedel A, Abreu A, Corra U, Davos C, Doehner W, Doherty P, Frederix I, Hansen D, Christine Iliou M, Vigorito C, Völler H; Secondary Prevention and Rehabilitation of the European Association of Preventive Cardiology (EAPC). The importance of return to work: How to achieve optimal reintegration in ACS patients. Eur J Prev Cardiol. 2019 Sep;26(13):1358-1369. doi: 10.1177/2047487319839263. Epub 2019 Apr 10. Review. — View Citation

Scherrenberg M, Falter M, Dendale P. Providing comprehensive cardiac rehabilitation during and after the COVID-19 pandemic. Eur J Prev Cardiol. 2021 May 14;28(5):520-521. doi: 10.1093/eurjpc/zwaa107. — View Citation

Thomas RJ, Beatty AL, Beckie TM, Brewer LC, Brown TM, Forman DE, Franklin BA, Keteyian SJ, Kitzman DW, Regensteiner JG, Sanderson BK, Whooley MA. Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology. Circulation. 2019 Jul 2;140(1):e69-e89. doi: 10.1161/CIR.0000000000000663. Epub 2019 May 13. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Physical activity derived from the International Physical Activity questionnaire (IPAQ) self-reported physical activity measured in metabolic equivalents (MET-min/week) Minimum value: 0, maximum value 19,278. Higher scores mean a better outcome. 10 months
Secondary Maximal oxygen uptake Maximal oxygen uptake during the final 30 seconds of the cardiopulmonary exercise testing (CPET) (ml/kg/min ) 10 months
Secondary Maximal heart rate Maximal heart rate at the end of the exercise testing (bpm) 10 months
Secondary Exercise time stress test duration (minutes) 10 months
Secondary Lipid parameters Total cholesterol (mg/dL), HDL cholesterol (mg/dL), LDL cholesterol (mg/dL), Non-HDL cholesterol (mg/dL), Triglycerides (mg/dL), Apolipoprotein B/Apolipoprotein A-I ratio 10 months
Secondary Glycosylated haemoglobin Percentage 10 months
Secondary Weight Kg 4 and 10 months
Secondary Waist circumference waist circumference change (cm) 4 and 10 months
Secondary Visceral fat Percentage 4 and 10 months
Secondary energy expenditure obtained from the International Physical Activity questionnaire (IPAQ) questionaire Kcal/week 10 months
Secondary High level of effort obtained from the International Physical Activity questionnaire (IPAQ) questionaire Percentage 10 months
Secondary Total score of Adherence to Mediterranean Diet obtained from the Prevention with Mediterranean Diet questionnaire (PREDIMED). Units. Minimum value: 0, maximum value: 14. Higher scores mean a better outcome. 10 months
Secondary High level of Adherence to Mediterranean Diet obtained from the Prevention with Mediterranean Diet questionnaire (PREDIMED) percentage. Minimum value: 0%, maximum value: 100%. Higher scores mean a better outcome. 10 months
Secondary Global score of emotional distress obtained from the Hospital Anxiety and Depression Scale (HADS) Units. Minimum value: 0, maximum value: 14. Lower scores mean a better outcome. 10 months
Secondary Anxiety subscale of emotional distress obtained from the Hospital Anxiety and Depression Scale (HADS) Units. Minimum value: 0, maximum value: 7. Lower scores mean a better outcome. 10 months
Secondary Depression subscale of Emotional distress obtained from the Hospital Anxiety and Depression Scale (HADS) Units. Minimum value: 0, maximum value: 7. Lower scores mean a better outcome. 10 months
Secondary Global index of the health-related quality of life obtained from the European Quality of Life questionnaire (EuroQol-5D) Units. Minimum value: 0, maximum value: 1. Higher scores mean a better outcome. 10 months
Secondary Health status obtained from the European Quality of Life questionnaire (EuroQol-5D) Units. Minimum value: 0, maximum value: 100. Higher scores mean a better outcome. 10 months
Secondary smoking cessation percentage 10 months
Secondary Time to start the rehabilitation programme after discharge from hospital days 10 months
Secondary Returning to work days 10 months
Secondary Pulse wave velocity m/s 10 months
Secondary User's experience from the System Usability Scale (SUS) score Units. Minimum value: 0, maximum value: 100. Higher scores mean a better outcome. 10 months
Secondary Cost-effectiveness analysis net cost divided by changes in health outcomes 10 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04475380 - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Completed NCT05466825 - Global Cardiovascular Risk Consortium
Completed NCT02290080 - Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers Phase 3
Completed NCT00692991 - Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures N/A
Recruiting NCT03715582 - Trimetazidine in Myocardial Injury After Percutaneous Coronary Intervention in Patients With Angina and Diabetes Phase 3
Recruiting NCT02760732 - Drug Eluting Balloon for Treatment of Unstable Angina N/A
Completed NCT01331707 - DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers Population Phase 4
Completed NCT00091507 - IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium. Phase 3
Completed NCT00269893 - A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-platelet Therapy, in Patients Undergoing High-risk Coronary Angioplasty Phase 3
Completed NCT02983123 - One-hour Troponin in a Low-prevalence Population of Acute Coronary Syndrome
Recruiting NCT06075602 - COMPLEX Registry - A Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting With compLEX and Calcified Coronary Artery Disease
Completed NCT02925923 - Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel Phase 2
Completed NCT00354328 - Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy
Completed NCT00269906 - A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients With Unstable Angina Not Responding to Standard Medical Therapy Who Are Eligible for Coronary Angioplasty Phase 3
Completed NCT03518645 - Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds N/A
Completed NCT00133003 - Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2) Phase 4
Completed NCT01617863 - Hemodynamics During the Soccer Championship 2012 N/A
Completed NCT02581540 - Mersey Acute Coronary Syndrome Rule-Out Using High Sensitive Troponin
Completed NCT00905671 - Intravascular Near Infrared Spectroscopy (NIRS) Bifurcation - Lipid Core Plaque Shift Study Phase 4
Terminated NCT00435487 - Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome Phase 4